STAA NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

STAAR Surgical Company · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data
Latest close 24.36 USD
4.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 1.9% above the Trend Line and sits at 43.3% of its 52-week range. The latest completed week returned 4.2%, after a -12.3% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 49/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: earnings are due in 4d.

Setup score 32 out of 100
Latest Close 24.36 USD 31 Jul 2026
1W Return 4.2% latest completed week
4W Return -12.3% short-term follow-through
12W Return -8.7% quarterly tape
Trend Breadth 61.5% 32 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 11-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 40.31% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.2% Latest completed week; four-week move -12.3%. Indicator stack 72/30 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 40.31% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 49/100 conviction; expected move 15.0%. News sentiment 54/100 58 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 1.9% above the Trend Line and sits at 43.3% of its 52-week range. The latest completed week returned 4.2%, after a -12.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6812-week average 0.68

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.68Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -12.3% over four weeks, -8.7% over 12 weeks, and 37.2% over one year. The current trend has remained active for 11 consecutive weeks.

Performance by holding period

1W4.2%
4W-12.3%
12W-8.7%
26W28.5%
52W37.2%
Active trend streak11 weeks
Active weeks in one year32
Trend breadth61.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.32Latest activity-pressure read.
Pressure change-175.2%Four-week change in activity pressure.
Leadership-10.43Latest relative-leadership reading.
RS change-1902.8%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength14/100Blend of value, momentum, and quality. Underlying universe rank 87; rank 1 is best.
Value23/100Relative valuation strength. Underlying universe rank 78; rank 1 is best.
Quality5/100Profitability and accounting quality. Underlying universe rank 96; rank 1 is best.
Momentum76/100Medium-term price momentum. Underlying universe rank 25; rank 1 is best.
Growth32/100Revenue and earnings growth. Underlying universe rank 69; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
4.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-4.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
76.4%
Gross profit retained from each unit of revenue.
Operating margin
-4.4%
Operating profit retained from revenue.
Free-cash-flow margin
-15.6%
Free cash flow generated from revenue.
Return on invested capital
-3.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
4.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-444.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.7%
Net share repurchases relative to market value.
Shareholder yield
0.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
23.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

STAA shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.10, expected move of 15.0%, and Sharemaestro trend signal active.

Conviction49/100
Expected move15.0%
Put/call volume0.10
Pressure89
Speculation3
Volatility88
Trend agreement8
Open options detail
Insider activity13 / 7

13 acquisitions and 7 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 58 relevant articles.

18 positive · 32 neutral · 8 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
Options expected move15.0%Nearest-chain priced movement where available.
52-week drawdown-32.1%Distance below the 52-week high.
13-week volatility7.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+30.8%Week of 10 Apr.
Worst week-11.6%Week of 24 Jul.
Latest week+4.2%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses2
Sharp losses10
Recent vol7.4%13-week weekly-return volatility.
Base vol10.4%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew8.2% / -4.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis72/100

Latest 12-week confirmation: trend 11/12, activity pressure 10/12, relative leadership 7/12.

Activity pressure 0.68; No reversal markers Next-Week ExpectancyNegative 40.31%

Next-week expectancy is negative with a 40.31% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors26/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 33; Small Cap Core rank 75 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

STAA shows volatility options pressure with a 49/100 conviction score, put-call volume ratio of 0.10, expected move of 15.0%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 15.0% Sentiment54/100

Weighted news tone is neutral across 58 relevant articles.

STAAR Surgical Co (STAA) Institutional Confidence Insiders13 / 7

13 acquisitions and 7 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 05 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202624.36 USD4.2%23.91 USD29.02 USD-0.32-10.435.0MOn
24 Jul 202623.38 USD-11.6%23.89 USD29.18 USD-0.16-13.436.6MOn
17 Jul 202626.44 USD-4.8%23.89 USD29.38 USD0.09-3.654.3MOn
10 Jul 202627.76 USD-0.1%23.84 USD29.57 USD0.31-2.724.0MOn
3 Jul 202627.79 USD-5.1%23.72 USD29.75 USD0.43-0.522.6MOn
26 Jun 202629.29 USD0.6%23.64 USD29.89 USD0.586.103.5MOn
19 Jun 202629.12 USD2.6%23.55 USD30.04 USD0.661.262.2MOn
12 Jun 202628.37 USD-5.4%23.51 USD30.18 USD0.821.702.8MOn
5 Jun 202629.99 USD0.3%23.45 USD30.34 USD1.0710.373.0MOn
29 May 202629.89 USD-7.9%23.33 USD30.47 USD1.085.504.5MOn
22 May 202632.47 USD1.2%23.20 USD30.65 USD1.0718.294.5MOn
15 May 202632.07 USD20.2%22.99 USD30.83 USD0.9718.758.9MOff
8 May 202626.69 USD-1.8%22.76 USD31.03 USD0.85-1.083.6MOff
1 May 202627.19 USD5.9%22.76 USD31.26 USD0.976.193.6MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.